How do neurons die in neurodegenerative diseases?

Trends in Molecular Medicine

Volumn 7, Issue 8, 2001, Pages 339-344

  Kanazawa, Ichiro ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; DOPAMINE; FREE RADICAL; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; DOPAMINE METABOLISM; HUMAN; HUNTINGTON CHOREA; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; REVIEW; SENILE PLAQUE; SUBSTANTIA NIGRA;

EID: 0034897532     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02017-2     Document Type: Note

References (50)

1. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
2. Ageing and Parkinson's disease: Substantia nigra regional selectivity
3. Ubiquitin in motor neuron disease: Study at the light and electron microscope
4. Apoptosis, oncosis, and necrosis. An overview of cell death
5. The cell biology of α-amyloid protein and presenilin in Alzheimer's disease
6. Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1
7. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
8. Mechanisms of neuronal degeneration in Alzheimer's disease
9. Tau protein pathology in neurodegenerative diseases
10. Cerebral amyloidosis, aging and Alzheimer's disease; a contribution from studies on Down's syndrome
11. Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity
12. Mutation in the α-synuclein gene identified in families with Parkinson's disease
13. A Drosophila model of Parkinson's disease
14. Binding of α-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation
15. Familial parkinson disease gene product, parkin, is a ubiquitin-protein ligase
16. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis
17. Amyotrophic lateral sclerosis and structural defects in Cu-Zn superoxide dismutase
18. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation
19. Trinucleotide repeat length instability and age of onset in Huntington's disease
20. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
21. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
22. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription
23. Quantitative study on dendrites and dendritic spines in Alzheimer's disease and senile dementia
24. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease
25. Parkinsonsche krankheit (Paralysis agitans) und postencephalitischer Parkinsonismus. Versuch einer klinischanatomischen differentialdiagnose
26. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
27. Changes in shapes of surviving motor neurons in amyotrophic lateral sclerosis
28. Nuclear membrane indentations in Huntington's disease
29. Molecular biology of aging in the nervous system: A synopsis of the levels of mechanisms
30. The nervous system and aging
31. 4-Hydroxy-2-nonenal is cytotoxic and crosslinks cytoskeletal proteins in P19 neuroglial cultures
32. Advanced glycation endproducts in aging and Alzheimer's disease
33. Energetics in the pathogenesis of neurodegenerative diseases
34. Free radicals, oxidative stress, and neurodegeneration
35. Oxidative stress hypothesis in Alzheimer's disease
36. Oxidative stress in Huntington's disease
37. Glutamate neuorotoxicity and diseases of the nervous system
38. Oxidative stress: Its role in the pathogenesis of amyotrophic lateral sclerosis
39. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis
40. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis
41. Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis
42. Neurodegeneration in Lurcher mice caused by mutation in Δ2 glutamate receptor gene
43. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
44. Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease
45. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
46. Immunization with amyloid-β attenuates Alzheimer's disease-like pathology in the PDAPP mouse
47. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
48. Parkinson disease gene therapy moves toward the clinic
49. Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology
50. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity